Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 11027-63-7
2. Buddlejoside A
3. (-)-buddlejoside A
4. Agnoside
5. Jb24q0ot9g
6. [(1s,4ar,5s,7as)-5-hydroxy-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-7-yl]methyl 4-hydroxybenzoate
7. Unii-jb24q0ot9g
8. Agnusid
9. Chasteberry Oil
10. Vitex Negundo Oil
11. Agnuside [usp-rs]
12. Schembl382107
13. Chebi:2515
14. Chembl483223
15. Megxp0_000767
16. Acon1_000039
17. Dtxsid10149191
18. ((1s,4ar,5s,7as)-5-hydroxy-1-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-7-yl)methyl 4-hydroxybenzoate
19. Hy-n2518
20. Zinc4098330
21. Mfcd00210471
22. Akos015896848
23. Ncgc00168851-01
24. Ncgc00168851-03
25. As-79164
26. Cs-0022789
27. C09765
28. Brd-k25132901-001-01-5
29. Q16826128
30. .beta.-d-glucopyranoside, (1s,4ar,5s,7as)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(((4-hydroxybenzoyl)oxy)methyl)cyclopenta(c)pyran-1-yl
31. .beta.-d-glucopyranoside, 1,4a,5,7a-tetrahydro-5-hydroxy-7-(((4-hydroxybenzoyl)oxy)methyl)cyclopenta(c)pyran-1-yl, (1.alpha.,4a.alpha.,5.alpha.,7a.alpha.)-
32. [(1s,4ar,5s,7as)-1-(beta-d-glucopyranosyloxy)-5-hydroxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-7-yl]methyl 4-hydroxybenzoate
33. [(1s,4ar,5s,7as)-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-7-yl]methyl 4-hydroxybenzoate
34. Ncgc00168851-03_c22h26o11_[(1s,4ar,5s,7as)-1-(beta-d-glucopyranosyloxy)-5-hydroxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-7-yl]methyl 4-hydroxybenzoate
Molecular Weight | 466.4 g/mol |
---|---|
Molecular Formula | C22H26O11 |
XLogP3 | -1.1 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 7 |
Exact Mass | 466.14751164 g/mol |
Monoisotopic Mass | 466.14751164 g/mol |
Topological Polar Surface Area | 175 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 747 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Agnuside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Agnuside, including repackagers and relabelers. The FDA regulates Agnuside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Agnuside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Agnuside supplier is an individual or a company that provides Agnuside active pharmaceutical ingredient (API) or Agnuside finished formulations upon request. The Agnuside suppliers may include Agnuside API manufacturers, exporters, distributors and traders.
Agnuside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Agnuside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Agnuside GMP manufacturer or Agnuside GMP API supplier for your needs.
A Agnuside CoA (Certificate of Analysis) is a formal document that attests to Agnuside's compliance with Agnuside specifications and serves as a tool for batch-level quality control.
Agnuside CoA mostly includes findings from lab analyses of a specific batch. For each Agnuside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Agnuside may be tested according to a variety of international standards, such as European Pharmacopoeia (Agnuside EP), Agnuside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Agnuside USP).
LOOKING FOR A SUPPLIER?